VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Holdings in DENTSPLY SIRONA Inc. $XRAY

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 225,700 shares of the medical instruments supplier’s stock, valued at approximately $2,395,000. VIRGINIA RETIREMENT SYSTEMS ET Al owned about 0.11% of DENTSPLY SIRONA at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of DENTSPLY SIRONA during the first quarter worth approximately $26,000. Goldman Sachs Group Inc. increased its position in DENTSPLY SIRONA by 827.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after acquiring an additional 2,172,343 shares during the period. Empowered Funds LLC increased its position in DENTSPLY SIRONA by 8.8% in the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 1,320 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in DENTSPLY SIRONA by 7.5% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 593,021 shares of the medical instruments supplier’s stock valued at $8,860,000 after acquiring an additional 41,579 shares in the last quarter. Finally, Focus Partners Wealth raised its stake in DENTSPLY SIRONA by 59.1% during the 1st quarter. Focus Partners Wealth now owns 25,181 shares of the medical instruments supplier’s stock valued at $376,000 after acquiring an additional 9,355 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Barrington Research set a $15.00 price target on DENTSPLY SIRONA in a research note on Monday, August 10th. BMO Capital Markets restated a “market perform” rating and set a $13.00 price objective on shares of DENTSPLY SIRONA in a research note on Friday, August 7th. Piper Sandler upped their price objective on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. Barclays increased their target price on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research report on Monday, August 24th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. Three research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $13.54.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $10.50 on Friday. DENTSPLY SIRONA Inc. has a 1 year low of $9.40 and a 1 year high of $14.76. The firm has a market cap of $2.09 billion, a P/E ratio of -3.82, a PEG ratio of 1.36 and a beta of 0.84. The stock has a fifty day moving average price of $12.15 and a two-hundred day moving average price of $11.62. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.17. The company had revenue of $898.00 million for the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The company’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.52 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts forecast that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current fiscal year.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Brian Gladden purchased 9,985 shares of the company’s stock in a transaction on Monday, June 15th. The shares were purchased at an average cost of $10.02 per share, for a total transaction of $100,049.70. Following the completion of the transaction, the director owned 61,849 shares in the company, valued at $619,726.98. The trade was a 19.25% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.46% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.